GlassScriptPhysician profile
Jason T Riley
NPI 1477752053
$4,445.96
in general payments reported to CMS, 2019-2025
20 companies · $685 in 2025
The $685 reported for 2025 was more than what 84% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $753 · 2020: $428 · 2021: $477 · 2022: $888 · 2023: $541 · 2024: $674 · 2025: $685.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,877 · Entertainment: $22.31.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,877.39 |
| Entertainment | $22.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $1,039.01 | 2022-2025 | Infuse, Biotrue, Biotrue One Day |
| Allergan, INC. | $503.82 | 2019-2022 | |
| Johnson & Johnson Vision Care, INC. | $419.34 | 2022-2025 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $396.00 | 2019-2021 | |
| Alcon Vision LLC | $296.14 | 2019-2025 | Precision 1, Precision7, Total30 |
| Coopervision INC. | $269.07 | 2019-2024 | Misight Contact Lens |
| Novartis Pharmaceuticals Corporation | $251.54 | 2020-2021 | |
| Sun Pharmaceutical Industries INC. | $248.96 | 2019-2022 | |
| Abbvie INC. | $223.67 | 2023-2024 | Durysta |
| Kala Pharmaceuticals, INC. | $124.43 | 2019 | |
| Lkc Technologies, INC. | $118.65 | 2023-2025 | |
| Harrow Eye, LLC | $117.02 | 2025 | Vevye |
| Dompe US, INC. | $92.78 | 2021 | |
| Rxsight INC | $88.96 | 2024 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Johnson & Johnson Surgical Vision, INC. | $79.45 | 2023-2024 | Tecnis Iol, Tecnis Iol |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $76.59 | 2022 | |
| Biotissue Holdings INC. | $35.88 | 2024 | |
| Lombart Brothers, INC. | $22.94 | 2023 | Opd-III |
| Optos, INC. | $22.31 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Riley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.